核酸抽出装置・試薬市場レポート：動向、予測、競合分析 (2031年まで)

世界の核酸抽出装置・試薬市場の将来は、学術研究機関、病院・診断センター、製薬・バイオテクノロジー、受託研究機関市場の機会で有望視されています。世界の核酸抽出装置・試薬市場は、2025年から2031年にかけてCAGR 10.4％で成長すると予想されます。この市場の主な促進要因は、オーダーメイド治療への関心の高まり、慢性疾患の発生率の増加、医療診断の発展の拡大です。

• Lucintelの予測では、種類別では装置が最も高い成長が見込まれています。
• 最終用途別では、学術研究機関が最も高い成長が見込まれています。
• 地域別では北米が最も高い成長が見込まれます。

核酸抽出機器・試薬市場の戦略的成長機会

核酸抽出装置・試薬市場は、技術の進歩と効率的な診断ソリューションに対する需要の増加により、成長の機が熟しています。企業は、進化する市場ニーズに対応し、医療、研究、バイオテクノロジーを含む様々な分野へのリーチを拡大するいくつかの戦略的機会を活用することができます。

• 新興市場への進出：新興国市場で医療インフラが整備されるにつれ、核酸抽出技術に対する需要が高まっています。企業はこれらの地域に戦略的に投資することで、現地のニーズに合わせた手頃で利用しやすいソリューションを提供することができます。現地のディストリビューターや医療提供者とのパートナーシップを確立することで、市場への浸透を強化し、成長を促進することができます。
• カスタム型ソリューションの開発：特定の用途やユーザーのニーズに合わせて核酸抽出装置・試薬をカスタマイズすることは、大きな成長の可能性をもたらします。研究機関や臨床検査室と協力することで、メーカーはさまざまなサンプルタイプや抽出方法に対応する特化した製品を設計し、ユーザーの満足度と市場競争力を高めることができます。
• AIと機械学習の統合：人工知能（AI）と機械学習技術の核酸抽出プロセスへの統合は、効率と精度を高める機会を提供します。これらの技術は、抽出プロトコルを最適化し、収量を向上させ、処理時間を短縮することができるため、高性能のソリューションを求める最新のラボにとって魅力的な機能となっています。
• 個別化医療への注目：個別化医療の台頭は、核酸抽出企業にとってまたとないチャンスです。個別化治療においてゲノミクスが重要な役割を果たすにつれ、高品質の核酸抽出に対する需要が高まっています。ゲノム研究や精密医療をサポートする堅牢なソリューションを開発することで、企業はこの成長市場の最前線に立つことができます。
• パートナーシップとコラボレーション：バイオテクノロジー企業、学術機関、診断薬企業との戦略的パートナーシップは、イノベーションを促進し、市場リーチを拡大することができます。共同研究により、最先端の抽出技術の開発が促進され、がん研究、感染症診断、遺伝子研究など、さまざまな分野で核酸検査の応用が広がります。

核酸抽出装置・試薬市場は、技術の進歩と世界の需要の増加により、数多くの戦略的成長機会を提供しています。新興市場、カスタマイズされたソリューション、AIのような革新的技術に注力することで、企業は競合情勢の中で成功するためのポジションを確立することができます。さらに、コラボレーションやパートナーシップは、製品提供を強化し、市場リーチを拡大することができるため、企業は医療や研究分野の進化するニーズに対応するための十分な設備を確保することができます。市場が進化し続ける中、こうした機会を捉えることは、長期的な成長とイノベーションにとって極めて重要です。

核酸抽出装置・試薬市場の促進要因・課題

核酸抽出装置・試薬市場は、成長を促進するさまざまな要因の影響を受ける一方で、企業が乗り越えなければならないいくつかの課題にも直面しています。これらの原動力を理解することは、戦略を最適化し、この急速に進化する分野における新たな機会を活用しようとする利害関係者にとって不可欠です。

核酸抽出装置・試薬市場を牽引する要因には、以下のようなものがあります：

• 診断検査需要の拡大：診断検査に対する需要の高まり：遺伝性疾患や感染症の有病率の増加により、正確な診断検査に対する需要が高まっています。この動向は、効果的な検査や治療に必要な高品質のサンプルを製造するために不可欠であるため、信頼性の高い核酸抽出技術の必要性を高めています。
• バイオテクノロジーの進歩：バイオテクノロジーの急速な進歩が、核酸抽出法の技術革新を後押ししています。自動化システムや磁気ビーズベースの抽出などの新技術は、効率性と信頼性を高めています。これらの技術革新は、研究室のワークフローを改善するだけでなく、ハイスループットなソリューションを求める研究者や臨床医のニーズの高まりにも対応しています。
• ゲノミクスへの投資の増加：ゲノミクス研究への投資の急増は、核酸抽出装置と試薬の需要を促進しています。個別化医療や医薬品開発のためにゲノミクスに注目する機関が増えるにつれ、高度な抽出技術の必要性がますます重要になり、市場関係者に大きな成長機会をもたらしています。
• 分子診断薬に対する規制支援：分子診断薬に対する支援的な規制の枠組みが市場の成長を促進しています。政府や規制機関は、核酸ベースの検査法の開発と採用を奨励しており、厳しい品質基準を満たす抽出技術や試薬の需要をさらに刺激しています。
• 個別化医療に対する意識の高まり：個別化医療に対する意識の高まりと実践は、高度な核酸抽出ソリューションに対する需要を生み出しています。医療が遺伝子情報に基づくオーダーメイド治療へとシフトするにつれ、効率的で正確な抽出方法の必要性が最も重要になり、市場拡大の原動力となっています。

核酸抽出装置・試薬市場の課題は以下の通りです：

• 先端技術の高コスト：核酸抽出市場が直面する重要な課題の1つは、先端技術や自動化システムに伴うコストの高さです。新興市場の小規模ラボや施設では、こうした高価格の機器への投資に苦慮し、効率的な抽出法へのアクセスが制限される可能性があります。
• 規制上のハードル：核酸抽出市場は、新製品の承認や商業化を遅らせかねない複雑な規制環境を乗り切らなければなりません。厳格な品質・安全基準の遵守には多大な資源と時間が必要であり、革新的なソリューションを迅速に市場に投入しようとする企業にとって課題となります。
• 競合と市場の飽和：核酸抽出技術の需要が高まるにつれ、市場競争は激化しています。多くの企業がこの分野に参入しており、飽和の可能性があります。各社は、市場シェアを維持し、進化する顧客ニーズに対応するために、提供する製品を差別化し、継続的に革新していかなければなりません。

核酸抽出装置・試薬市場は、技術の進歩と診断検査需要の増加に牽引され、チャンスに富んだ市場となっています。高コスト、規制上のハードル、競合といった課題が存在する一方で、これらの課題に戦略的に対処することで、企業は成功を収めることができます。成長促進要因を活用し、課題を効果的に克服することで、利害関係者は医療および研究部門の進化するニーズを活用することができ、このダイナミックな市場で長期的な成功を収めることができます。

目次

第1章 エグゼクティブサマリー

第2章 世界の核酸抽出装置・試薬市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界の核酸抽出装置・試薬市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界の核酸抽出装置・試薬市場：種類別
  • 装置
  • スピンコラム
  • ビーズ/磁気ビーズ
  • 自動核酸抽出システム
  • 抽出キット・試薬・消耗品
  • その他
• 世界の核酸抽出装置・試薬市場：抽出の種類別
  • DNA抽出
  • DNA/RNA抽出
  • RNA抽出
• 世界の核酸抽出装置・試薬市場：手法別
  • 溶液ベースの手法
  • 固相ベースの手法
• 世界の核酸抽出装置・試薬市場：最終用途別
  • 学術研究機関
  • 病院・診断センター
  • 製薬・バイオテクノロジー
  • CRO（医薬品開発業務受託機関）
  • その他

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界の核酸抽出装置・試薬市場：地域別
• 北米の核酸抽出装置・試薬市場
• 欧州の核酸抽出装置・試薬市場
• アジア太平洋の核酸抽出装置・試薬市場
• その他地域の核酸抽出装置・試薬市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の核酸抽出装置・試薬市場の成長機会：種類別
  • 世界の核酸抽出装置・試薬市場の成長機会：抽出の種類別
  • 世界の核酸抽出装置・試薬市場の成長機会：手法別
  • 世界の核酸抽出装置・試薬市場の成長機会：最終用途別
  • 世界の核酸抽出装置・試薬市場の成長機会：地域別
• 世界の核酸抽出装置・試薬市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の核酸抽出装置・試薬市場の生産能力拡大
  • 世界の核酸抽出装置・試薬市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Thermo Fisher Scientific
• F Hoffmann-La Roche
• Merck Group
• Corning Incorporated
• Agilent Technologies
• PerkinElmer
• Illumina
• Beckman Coulter
• Bio-Rad Laboratories
• Qiagen

The future of the global nucleic acid extraction instrument and reagent market looks promising with opportunities in the academic research institute, hospitals & diagnostic centers, pharmaceutical & biotechnology, and contract research organization markets. The global nucleic acid extraction instrument and reagent market is expected to grow with a CAGR of 10.4% from 2025 to 2031. The major drivers for this market are the rising interest in customized treatment, the increase in the occurrence of chronic illnesses, and the growing development of medical diagnostics.

• Lucintel forecasts that, within the type category, the instruments is expected to witness the highest growth.
• Within this end use category, academic research institutes is expected to witness the highest growth.
• In terms of regions, North America is expected to witness the highest growth.

Gain Valuable Insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Nucleic Acid Extraction Instrument and Reagent Market

The nucleic acid extraction instrument and reagent market is evolving rapidly, driven by technological advancements and increasing demand for accurate diagnostics. These emerging trends reflect the industry's response to the growing need for efficient, reliable, and scalable solutions across various applications, from clinical diagnostics to research.

• Integration of Automation: Automation is becoming increasingly prevalent in nucleic acid extraction processes, reducing human error and increasing throughput. Automated systems enable laboratories to handle higher sample volumes with consistent results, improving efficiency and allowing for real-time monitoring of extraction protocols.
• Miniaturization of Instruments: There is a growing trend toward the miniaturization of nucleic acid extraction instruments. Compact devices offer portability and ease of use, making them suitable for point-of-care testing and field applications. This shift enhances accessibility and reduces reagent consumption, aligning with sustainability goals.
• Use of Magnetic Bead Technology: Magnetic bead-based extraction methods are gaining traction due to their efficiency and versatility. This technology simplifies the extraction process, enabling quicker and more effective isolation of nucleic acids while minimizing contamination risks. Its compatibility with various sample types drives widespread adoption across laboratories.
• Focus on Cost-Effective Solutions: As demand for nucleic acid testing increases globally, there is a heightened focus on developing cost-effective extraction solutions. Manufacturers are innovating to provide affordable reagents and instruments, making high-quality nucleic acid extraction accessible to a broader range of laboratories, especially in emerging markets.
• Emphasis on Quality Control: Quality control measures are becoming increasingly important in the nucleic acid extraction process. An enhanced focus on the standardization and validation of extraction protocols ensures reproducibility and reliability, particularly in clinical settings. This trend is vital for regulatory compliance and meeting the stringent demands of diagnostic applications.

The nucleic acid extraction market is poised for significant advancements driven by automation, miniaturization, and innovative technologies. As the demand for reliable and efficient diagnostic solutions grows, the industry is responding with cost-effective and high-quality products. These emerging trends enhance laboratory capabilities and improve accessibility for a broader range of users, including those in resource-limited settings. Ultimately, the ongoing evolution of this market will play a critical role in advancing molecular biology and clinical diagnostics, ensuring better health outcomes globally.

Recent Developments in the Nucleic Acid Extraction Instrument and Reagent Market

The nucleic acid extraction instrument and reagent market is undergoing rapid transformation, characterized by significant technological advancements and innovations. These developments enhance the efficiency, reliability, and accessibility of nucleic acid extraction methods, catering to diverse applications in research, diagnostics, and biotechnology.

• Advancements in Automation: The integration of automated systems in nucleic acid extraction processes has revolutionized laboratory workflows. These systems minimize human error and significantly increase throughput, allowing labs to process larger sample volumes efficiently. Automation also enables real-time monitoring, ensuring consistent quality and performance across multiple runs.
• Emergence of Integrated Solutions: There is a notable trend toward integrated platforms that combine nucleic acid extraction with downstream applications, such as PCR and sequencing. These all-in-one solutions streamline workflows, reduce sample handling steps, and enhance overall efficiency. By facilitating a seamless transition from extraction to analysis, integrated solutions are increasingly favored in both research and clinical settings.
• Enhanced Reagent Formulations: Recent developments in reagent formulations have led to improved extraction efficiency and yield. Novel reagents are designed to optimize the binding and elution of nucleic acids, resulting in higher-quality samples. These enhancements address the needs of various applications, from clinical diagnostics to genetic research, ultimately supporting more reliable results.
• Focus on Point-of-Care Testing: The demand for point-of-care (POC) testing has spurred innovations in nucleic acid extraction technologies. Portable and user-friendly devices are being developed to enable rapid testing in diverse settings, including remote areas. This trend addresses the urgent need for timely diagnostics, particularly in infectious disease outbreaks and resource-limited environments.
• Sustainability Initiatives: Increasing awareness of environmental concerns is driving sustainability initiatives within the nucleic acid extraction market. Manufacturers are focusing on developing eco-friendly reagents and instruments that minimize waste and reduce environmental impact. This shift not only aligns with global sustainability goals but also appeals to laboratories striving to adopt greener practices.

The nucleic acid extraction instrument and reagent market is marked by key developments that enhance efficiency, integration, and sustainability. With advancements in automation, integrated solutions, and eco-friendly practices, the market is evolving to meet the growing demands of research and diagnostics. These innovations are critical for improving the reliability and accessibility of nucleic acid testing, ultimately contributing to better health outcomes and advancing scientific discovery. As the landscape continues to change, the industry is well-positioned for future growth and transformation.

Strategic Growth Opportunities for Nucleic Acid Extraction Instrument and Reagent Market

The nucleic acid extraction instrument and reagent market is ripe for growth, driven by advancements in technology and increasing demand for efficient diagnostic solutions. Companies can capitalize on several strategic opportunities that cater to evolving market needs and expand their reach across various sectors, including healthcare, research, and biotechnology.

• Expansion into Emerging Markets: As healthcare infrastructure develops in emerging markets, there is growing demand for nucleic acid extraction technologies. Companies can strategically invest in these regions to offer affordable and accessible solutions tailored to local needs. Establishing partnerships with local distributors and healthcare providers can enhance market penetration and drive growth.
• Development of Customized Solutions: Tailoring nucleic acid extraction instruments and reagents to meet specific applications and user needs presents significant growth potential. By collaborating with research institutions and clinical laboratories, manufacturers can design specialized products that cater to various sample types and extraction methods, enhancing user satisfaction and market competitiveness.
• Integration of AI and Machine Learning: The integration of artificial intelligence (AI) and machine learning technologies into nucleic acid extraction processes offers opportunities for enhanced efficiency and accuracy. These technologies can optimize extraction protocols, improve yield, and reduce processing times, making them attractive features for modern laboratories seeking high-performance solutions.
• Focus on Personalized Medicine: The rise of personalized medicine presents a unique opportunity for nucleic acid extraction companies. As genomics plays a crucial role in tailored therapies, the demand for high-quality nucleic acid extraction is increasing. By developing robust solutions that support genomic studies and precision medicine, companies can position themselves at the forefront of this growing market.
• Partnerships and Collaborations: Strategic partnerships with biotech firms, academic institutions, and diagnostic companies can foster innovation and expand market reach. Collaborative efforts can facilitate the development of cutting-edge extraction technologies and broaden the application of nucleic acid testing in various fields, including cancer research, infectious disease diagnostics, and genetic studies.

The nucleic acid extraction instrument and reagent market offers numerous strategic growth opportunities, driven by technological advancements and increasing global demand. By focusing on emerging markets, customized solutions, and innovative technologies like AI, companies can position themselves for success in a competitive landscape. Additionally, collaborations and partnerships can enhance product offerings and expand market reach, ensuring that businesses are well-equipped to meet the evolving needs of healthcare and research sectors. As the market continues to evolve, seizing these opportunities will be crucial for long-term growth and innovation.

Nucleic Acid Extraction Instrument and Reagent Market Driver and Challenges

The nucleic acid extraction instrument and reagent market is influenced by various drivers that foster growth while facing several challenges that companies must navigate. Understanding these dynamics is essential for stakeholders looking to optimize their strategies and capitalize on emerging opportunities in this rapidly evolving sector.

The factors responsible for driving the nucleic acid extraction instrument and reagent market include:

• Growing Demand for Diagnostic Testing: The increasing prevalence of genetic disorders and infectious diseases has heightened the demand for accurate diagnostic testing. This trend drives the need for reliable nucleic acid extraction technologies, as they are critical for producing high-quality samples necessary for effective testing and treatment.
• Advancements in Biotechnology: Rapid advancements in biotechnology are propelling innovation in nucleic acid extraction methods. New technologies, such as automated systems and magnetic bead-based extraction, enhance efficiency and reliability. These innovations not only improve lab workflows but also cater to the growing needs of researchers and clinicians for high-throughput solutions.
• Rising Investment in Genomics: The surge in investment in genomics research is driving demand for nucleic acid extraction instruments and reagents. As more institutions focus on genomics for personalized medicine and drug development, the need for advanced extraction technologies becomes increasingly crucial, presenting significant growth opportunities for market players.
• Regulatory Support for Molecular Diagnostics: Supportive regulatory frameworks for molecular diagnostics are fostering market growth. Governments and regulatory bodies are encouraging the development and adoption of nucleic acid-based testing methods, which further stimulate demand for extraction technologies and reagents that meet stringent quality standards.
• Increased Awareness of Personalized Medicine: The growing awareness and implementation of personalized medicine are creating a demand for advanced nucleic acid extraction solutions. As healthcare shifts towards tailored treatments based on genetic information, the need for efficient and accurate extraction methods becomes paramount, driving market expansion.

Challenges in the nucleic acid extraction instrument and reagent market are:

• High Cost of Advanced Technologies: One significant challenge facing the nucleic acid extraction market is the high cost associated with advanced technologies and automated systems. Smaller laboratories and facilities in emerging markets may struggle to invest in these high-priced instruments, limiting their access to efficient extraction methods.
• Regulatory Hurdles: The nucleic acid extraction market must navigate complex regulatory environments that can slow down the approval and commercialization of new products. Adhering to stringent quality and safety standards requires significant resources and time, posing challenges for companies seeking to bring innovative solutions to market quickly.
• Competition and Market Saturation: As the demand for nucleic acid extraction technologies grows, the market is becoming increasingly competitive. Many players are entering the space, leading to potential saturation. Companies must differentiate their offerings and continuously innovate to maintain market share and address evolving customer needs.

The nucleic acid extraction instrument and reagent market presents a landscape rich with opportunities driven by technological advancements and increasing demand for diagnostic testing. While challenges such as high costs, regulatory hurdles, and competition exist, addressing these issues strategically can enable companies to thrive. By leveraging the growth drivers and navigating the challenges effectively, stakeholders can position themselves to capitalize on the evolving needs of the healthcare and research sectors, ensuring long-term success in this dynamic market.

List of Nucleic Acid Extraction Instrument and Reagent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies nucleic acid extraction instrument and reagent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nucleic acid extraction instrument and reagent companies profiled in this report include-

• Thermo Fisher Scientific
• F Hoffmann-La Roche
• Merck Group
• Corning Incorporated
• Agilent Technologies
• PerkinElmer
• Illumina
• Beckman Coulter
• Bio-Rad Laboratories
• Qiagen

Nucleic Acid Extraction Instrument and Reagent by Segment

The study includes a forecast for the global nucleic acid extraction instrument and reagent market by type, extraction type, method, end use, and region.

Nucleic Acid Extraction Instrument and Reagent Market by Type [Analysis by Value from 2019 to 2031]:

• Instruments
• Spin Columns
• Beads or Magnetic Beads
• Automated Nucleic Acid Extraction Systems
• Extraction Kits, Reagents & Consumables
• Others

Nucleic Acid Extraction Instrument and Reagent Market by Extraction Type [Analysis by Value from 2019 to 2031]:

• DNA Extraction
• DNA or RNA Extraction
• RNA Extraction

Nucleic Acid Extraction Instrument and Reagent Market by Method [Analysis by Value from 2019 to 2031]:

• Solution-Based Methods
• Solid-Phase-Based Methods

Nucleic Acid Extraction Instrument and Reagent Market by End Use [Analysis by Value from 2019 to 2031]:

• Academic Research Institutes
• Hospitals & Diagnostic Centers
• Pharmaceutical & Biotechnology
• Contract Research Organizations
• Others

Nucleic Acid Extraction Instrument and Reagent Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Nucleic Acid Extraction Instrument and Reagent Market

The nucleic acid extraction instrument and reagent market is witnessing significant growth across key regions, fueled by advancements in technology and increasing demand for efficient diagnostic solutions. In the U.S., innovations in automation are enhancing extraction processes, while China is ramping up domestic production and affordability. Germany leads with a focus on AI integration, and India is expanding through collaborations to meet diverse needs. Meanwhile, Japan's emphasis on precision and miniaturization is driving the development of compact, high-quality systems. Together, these trends reflect a dynamic and rapidly evolving landscape in the nucleic acid extraction industry.

• U.S.: In the U.S., the nucleic acid extraction market is experiencing significant growth driven by advancements in automation and efficiency. Companies are investing in innovative technologies to enhance extraction processes, aiming to meet the increasing demand for rapid and reliable diagnostics, particularly in the context of infectious diseases.
• China: China has seen a surge in domestic production of nucleic acid extraction instruments, supported by government initiatives to bolster biotechnology sectors. The focus on affordable, high-throughput solutions is driving competition, with local companies rapidly adopting international standards to enhance quality and reliability.
• Germany: Germany continues to be a leader in the nucleic acid extraction market, with a strong emphasis on research and development. German manufacturers are integrating AI and machine learning into their instruments to optimize extraction protocols, ensuring higher yields and improved accuracy, thereby supporting both clinical and research applications.
• India: In India, the nucleic acid extraction market is expanding due to increasing investment in biotechnology and healthcare infrastructure. Local firms are collaborating with international partners to enhance their product offerings, focusing on cost-effective solutions that cater to the diverse needs of hospitals and research institutions.
• Japan: Japan is advancing in the nucleic acid extraction field through innovations in precision and miniaturization. The country's strong focus on automation and robotics in laboratory processes is leading to the development of compact, efficient extraction systems, enhancing throughput while maintaining high-quality standards for both research and clinical diagnostics.

Features of the Global Nucleic Acid Extraction Instrument and Reagent Market

Market Size Estimates: Nucleic acid extraction instrument and reagent market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Nucleic acid extraction instrument and reagent market size by various segments, such as by type, extraction type, method, end use, and region in terms of value ($B).

Regional Analysis: Nucleic acid extraction instrument and reagent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, extraction types, methods, end uses, and regions for the nucleic acid extraction instrument and reagent market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nucleic acid extraction instrument and reagent market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the nucleic acid extraction instrument and reagent market by type (instruments, spin columns, beads or magnetic beads, automated nucleic acid extraction systems, extraction kits, reagents & consumables, and others), extraction type (DNA extraction, DNA or RNA extraction, and RNA extraction), method (solution-based methods and solid-phase-based methods), end use (academic research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology, contract research organizations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nucleic Acid Extraction Instrument and Reagent Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Nucleic Acid Extraction Instrument and Reagent Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Nucleic Acid Extraction Instrument and Reagent Market by Type
  • 3.3.1: Instruments
  • 3.3.2: Spin Columns
  • 3.3.3: Beads or Magnetic Beads
  • 3.3.4: Automated Nucleic Acid Extraction Systems
  • 3.3.5: Extraction Kits, Reagents & Consumables
  • 3.3.6: Others
• 3.4: Global Nucleic Acid Extraction Instrument and Reagent Market by Extraction Type
  • 3.4.1: DNA Extraction
  • 3.4.2: DNA Or RNA Extraction
  • 3.4.3: RNA Extraction
• 3.5: Global Nucleic Acid Extraction Instrument and Reagent Market by Method
  • 3.5.1: Solution-Based Methods
  • 3.5.2: Solid-Phase-Based Methods
• 3.6: Global Nucleic Acid Extraction Instrument and Reagent Market by End Use
  • 3.6.1: Academic Research Institutes
  • 3.6.2: Hospitals & Diagnostic Centers
  • 3.6.3: Pharmaceutical & Biotechnology
  • 3.6.4: Contract Research Organizations
  • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Nucleic Acid Extraction Instrument and Reagent Market by Region
• 4.2: North American Nucleic Acid Extraction Instrument and Reagent Market
  • 4.2.1: North American Market by Type: Instruments, Spin Columns, Beads or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits, Reagents & Consumables, and Others
  • 4.2.2: North American Market by End Use: Academic Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology, Contract Research Organizations, and Others
• 4.3: European Nucleic Acid Extraction Instrument and Reagent Market
  • 4.3.1: European Market by Type: Instruments, Spin Columns, Beads or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits, Reagents & Consumables, and Others
  • 4.3.2: European Market by End Use: Academic Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology, Contract Research Organizations, and Others
• 4.4: APAC Nucleic Acid Extraction Instrument and Reagent Market
  • 4.4.1: APAC Market by Type: Instruments, Spin Columns, Beads or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits, Reagents & Consumables, and Others
  • 4.4.2: APAC Market by End Use: Academic Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology, Contract Research Organizations, and Others
• 4.5: ROW Nucleic Acid Extraction Instrument and Reagent Market
  • 4.5.1: ROW Market by Type: Instruments, Spin Columns, Beads or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits, Reagents & Consumables, and Others
  • 4.5.2: ROW Market by End Use: Academic Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology, Contract Research Organizations, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by Type
  • 6.1.2: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by Extraction Type
  • 6.1.3: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by Method
  • 6.1.4: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by End Use
  • 6.1.5: Growth Opportunities for the Global Nucleic Acid Extraction Instrument and Reagent Market by Region
• 6.2: Emerging Trends in the Global Nucleic Acid Extraction Instrument and Reagent Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Nucleic Acid Extraction Instrument and Reagent Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nucleic Acid Extraction Instrument and Reagent Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: F Hoffmann-La Roche
• 7.3: Merck Group
• 7.4: Corning Incorporated
• 7.5: Agilent Technologies
• 7.6: PerkinElmer
• 7.7: Illumina
• 7.8: Beckman Coulter
• 7.9: Bio-Rad Laboratories
• 7.10: Qiagen